Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
79,719,412
-
Total 13F shares
-
16,362,026
-
Share change
-
+16,362,026
-
Total reported value
-
$527,472,000
-
Price per share
-
$32.31
-
Number of holders
-
50
-
Value change
-
+$527,472,105
-
Number of buys
-
50
Institutional Holders of Kymera Therapeutics, Inc. - COMMON STOCK (KYMR) as of Q3 2020
As of 30 Sep 2020 Kymera Therapeutics, Inc. - COMMON STOCK (KYMR) had 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 16,362,026 shares of stock of the company.
Largest 10 holders included Redmile Group, LLC, BVF INC/IL, FMR LLC, BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Bain Capital Life Sciences Investors, LLC, Rock Springs Capital Management LP, Logos Global Management LP, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 50 institutional shareholders of the security as of 30 Sep 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.